Bekaert - Update on the Liquidity Agreement
Tweet
Share
E-mail
Update on the Liquidity Agreement
Period from 12 September 2024 to 18 September 2024
Liquidity agreement
In relation to the renewed liquidity agreement with Kepler Cheuvreux announced on 25 June 2024, Bekaert announces today that Kepler Cheuvreux on behalf of Bekaert has bought 1 850 shares during the period from 12 September 2024 to 18 September 2024 on Euronext Brussels. During the same period, Kepler Cheuvreux on behalf of Bekaert has sold 11 400 shares on Euronext Brussels.
The tables below provide an overview of the transactions under the liquidity agreement during the period from 12 September 2024 to 18 September 2024:
| Purchase of shares | |||||
| Date | Number of Shares | Average Price (€) | Highest Price (€) | Lowest Price (€) | Total Amount (€) |
| 12 September 2024 | 1 400 | 34.25 | 34.40 | 34.00 | 47 950 |
| 13 September 2024 | 450 | 34.07 | 34.10 | 34.00 | 15 332 |
| 16 September 2024 | 0 | 0.00 | 0.00 | 0.00 | 0 |
| 17 September 2024 | 0 | 0.00 | 0.00 | 0.00 | 0 |
| 18 September 2024 | 0 | 0.00 | 0.00 | 0.00 | 0 |
| Total | 1 850 | 63 282 | |||
| Sale of shares | |||||
| Date | Number of Shares | Average Price (€) | Highest Price (€) | Lowest Price (€) | Total Amount (€) |
| 12 September 2024 | 1 500 | 34.51 | 34.68 | 34.20 | 51 765 |
| 13 September 2024 | 1 500 | 34.22 | 34.40 | 34.00 | 51 330 |
| 16 September 2024 | 2 400 | 34.61 | 34.72 | 34.40 | 83 064 |
| 17 September 2024 | 3 300 | 35.12 | 35.60 | 34.72 | 115 896 |
| 18 September 2024 | 2 700 | 36.07 | 36.40 | 35.70 | 97 389 |
| Total | 11 400 | 399 444 | |||
The balance held by Bekaert under the liquidity agreement at the end of the period is 36 868 shares.
On 18 September 2024 after closing of the market, Bekaert holds 1 848 997 own shares, or 3.41% of the total number of the outstanding shares.
This information is also made available on the investor relations pages of our website.
Attachment
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- HUTCHMED Announces SANOVO Trial Demonstrated Significant Progression-Free Survival Benefit of ORPATHYS® Plus TAGRISSO® in Treatment-Naïve Patients with MET-Overexpressing EGFR-mutated Lung Cancer i
- McKinney makes history … again … becoming the youngest AOY winner in B.A.S.S. history
- Faraday Future Founder and Global CEO YT Jia Shares Weekly Investor Update: New Robot Deliveries and Updates from the Middle East; Recap on FF EAI Robotics “Built in USA” Business Partner Conferen
Create E-mail Alert Related Categories
Globe Newswire, Press ReleasesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
